Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-γ production

International Journal of Experimental Pathology

Volumn 83, Issue 3, 2002, Pages 121-132

  Lagrota Candido, Jussara ^a   Vasconcellos, Rita ^a   Cavalcanti, Marta ^a   Bozza, Marcelo ^a   Savino, Wilson ^a   Quirico Santos, Thereza ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Immune system; Inflammation; Mdx; Muscular dystrophy

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUCHENNE MUSCULAR DYSTROPHY; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MALE; MOUSE; MUSCLE NECROSIS; MUSCLE REGENERATION; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELLS, CULTURED; CONCANAVALIN A; IMMUNOGLOBULINS; INTERFERON TYPE II; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; REGENERATION; T-LYMPHOCYTES;

EID: 0036404749     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2002.00221.x     Document Type: Article

References (38)

1. Allamand V. & Campbell K.P. (2000) Animal models for muscular dystrophy: Valuable tools for the development of therapies. Hum. Mol. Genet. 9, 2459-2467.
2. Amemiya K., Seminomora C., Granger R.P. & Dalakas M.C. (2000) Downregulation of TGF-β1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin. Immunol. 94, 99-104.
3. Bernasconi P., Torchiana E., Confalonieri P. et al. (1995) Expression of transforming growth factor-β1 in dystrophic patient muscles correlates with fibrosis. J. Clin. Invest. 96, 1137-1144.
4. Billiau A. (1996) Interferon-γ: Biology and role in pathogenesis. Adv. Immunol. 62, 61-109.
5. Boland B., Himpens B., Denef J.F. & Gillis J.M. (1995) Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse. Muscle & Nerve 18, 649-657.
6. Brown S.C., Fassati A., Popplewell L. et al. (1999) Dystrophic phenotype induced in vitro by antibody blockade of muscle α-dystroglycan-laminin interaction. J. Cell. Sci. 112, 209-216
7. DiMario J., Buffinger N., Yamada S. & Strohman C. (1989) Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 44, 688-690.
8. Foster R.F., Thompson J.M. & Kaufman S.J. (1987) A laminin substrate promotes myogenesis in rat skeletal muscle cultures: Analysis of replication and development using anti-desmin monoclonal antibodies. Dev. Biol. 122, 11-20.
9. Gradien A., Fucs R., Nobrega A., Anderson J. & Coutinho A. (1994) Negative selection of multireactive B cell clones in normal adult mice. Eur. J. Immunol. 24, 1345-1352.
10. Henriksson A., Kam-Hansen S., Forsberg P. & Gradien M. (1986) Cerebrospinal fluid lymphocytes from patients with multiple sclerosis do not increase immunoglobulin or measles antibody production after stimulation with pokeweed mitogen. J. Neuroimmunol. 11, 15-30.
11. Infante J.P. & Huszagh V.A. (1999) Mechanisms of resistance to pathogenesis in muscular dystrophies. Mol. Cell. Biochem. 195, 155-167.
12. Lagrota-Candido J., Vanderlei F.H.F., Villaverde D.M.S. & Savino W. (1996) Effects of interferon-γ upon thymic epithelial cell/thymocyte interactions mediated by extracellular matrix ligands and receptors. Cell. Immunol. 170, 235-244.
13. Lagrota-Candido J., Canella I., Savino W. & Quirico-Santos T. (1999) Expression of extracellular matrix ligands and receptors in the muscular tissue and draining lymph nodes of mdx dystrophic mice. Clin. Immunol. 93, 143-151.
14. Liu C., Wang H., Zhao Z. et al. (2000) MyoD-dependent induction during myoblast differentiation of p204, a protein also inducible by interferon. Mol. Cell. Biol. 20, 7024-7036.
15. Maegaki Y., Ogura K., Maeoka Y. & Takeshita K. (1999) Normalization of creatine kinase level during arthritis in a patient with Becker muscular dystrophy. Neurology 52, 172-174.
16. Matthys P., Vermeire K. & Mitera T. et al. (1999) Enhanced autoimmune arthritis in IFN-γ receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J. Immunol. 163, 3503-3510.
17. Matthys P., Vermeire K. & Billiau A. (2001) Mac-1+ myelopoiesis induced by CFA: A clue to the paradoxical effects of IFN-γ in autoimmune disease models. Trends Immunol. 22, 367-371.
18. McDowall R.M., Dunn M.J. & Dubowitz V. (1990) Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J. Neurol. Sci. 99, 199-217.
19. Mehler M.F. (2000) Brain dystrophin, neurogenetics and mental retardation. Brain Res. Rev. 32, 277-307.
20. Menko A.S. & Boettinger D. (1987) Occupation of extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell 51, 51-57.
21. Michaelis D., Goebels N. & Hohlfeld R. (1993) Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am. J. Pathol. 143, 1142-1149.
22. Mizoguchi A., Mizoguchi E., Smith R.N., Preffer F.I. & Bhan A.K. (1997) Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J. Exp. Med. 186, 1749-1756.
23. Morrison J., Lu Q.L., Pastoret C., Partridge T. & Bou-Guarious G. (2000) T-cell-dependent fibrosis in the mdx dystrophic mouse. Laboratory Invest. 80, 881-891.
24. Nonaka I. (1998) Animal models of muscular dystrophies. Laboratory Anim. Sci. 48, 8-16.
25. Oliveira V.R., El-Cheikh M.C., Aguiar A.M. et al. (2000) Schistosoma mansoni egg-induced hepatic granuloma in mice deficient for the interferon-gamma receptor have altered population of macrophages, lymphocytes and connective tissue cells. Microbes Infect. 2, 1817-1826
26. Pastoret C. & Sebille A. (1995) Mdx mice show progressive weakness and muscle deterioration with age. Neurol. Sci. 129, 97-105.
27. Quirico-Santos T., Ribeiro M.M. & Savino W. (1995) Increased deposition of extracellular matrix components in the thymus gland of mdx mouse: Correlation with the muscular lesion. J. Neuroimmunol. 59, 9-18.
28. Reyes-Reyna S.M. & Krolick K.A. (2000) Chemokine production by rat myocytes exposed to interferon-gamma. Clin. Immunol. 94, 105-113.
29. Roncarolo M.-G. & Levings M.K. (2000) The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12, 676-683.
30. Sakaguchi S. (2000) Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 101, 455-458.
31. Sedgwick D.J. & Holt P.G. (1983) A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Meth. 57, 301-309.
32. Seixas S.L., Lagrota-Candido J.M., Savino W. & Quirico-Santos T. (1997) The importance of mdx mouse in the pathophysiology of Duchenne's muscular dystrophy. Arq. Neuropsiquiatr. 55, 610-617.
33. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G. & Barnard P. (1989) The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 30, 1578-1580.
34. Spencer M.J., Montecino-Rodriguez E., Dorshkind K. & Tidball J.G. (2001) Helper (CD4+) and cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle. Clin. Immunol. 98, 235-243.
35. Spencer M.J., Walsh C.M., Dorshkind K.A., Rodriguez E.M. & Tidball J.G. (1997) Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J. Clin. Invest. 11, 2745-2751.
36. Tran E.H., Prince E.N. & Owens T. (2000) IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164, 2759-2768.
37. Yamamoto K., Yuasa K., Miyagoe Y. et al. (2000) Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice. Hum. Gene Ther. 11, 669-680.
38. Zhang G.-X., Xiao B.-G., Bai X.-F., van der Meide P.H., Orn A. & Link H. (1999) Mice with IFN-γ receptor deficiency are less susceptible to Experimental Autoimmune Myasthenia Gravis. J. Immunol. 162, 3775-3781.